THC Therapeutics Inc. Acquires SugarTop Buddery

*MEDFORD, Ore.* — THC Therapeutics Inc., a company focused on the legal and
regulated cannabis industry, acquired all issued and outstanding membership
interests of STHoldings Group LLC, the parent company of Eugene, Oregon,
cannabis brand SugarTop Buddery in an all-share transaction valued at
approximately $3 million. The deal was satisfied entirely through the
issuance of newly created Series D Preferred stock.

This marks THCT’s second strategic acquisition in its ongoing roll-up
strategy, following a June 2025 acquisition of The Headquarters Group. With
this second transaction, THCT expands its operations in Oregon and gains
ownership of a culturally significant craft cannabis company with deep
roots in the Pacific Northwest.

Founded in 2015, SugarTop Buddery is celebrating its 10-year anniversary.
The brand, built by co-founder and CEO Anna Kaplan, has long been
recognized for its commitment to artistry, equity, and sustainability,
receiving consistent praise from cannabis publications and retailers for
its emphasis on craft, culture, and the empowerment of women.

“This transaction is an opportunity not only for myself, but for the brand
I have spent the last decade building to have the future growth it
deserves,” said Kaplan. “Having fought our way through 10 years of
volatility in a mature market like Oregon, our move under the THCT umbrella
will provide the capital, infrastructure, and greater resources for
SugarTop Buddery and our family of brands to truly emerge on a national and
international stage. I am very much looking forward to engaging with new
markets on the East Coast and bringing the best of what craft cannabis can
be to the nation.”

STHoldings Group LLC includes not only SugarTop Buddery’s primary operating
company STB Enterprises LLC, but also STIP, an intellectual property
company holding the brand’s trademarks and media assets, and STH
Enterprises LLC, its hemp-focused subsidiary. Collectively, the entities
generated approximately $2.1 million in revenue in 2024, with peak
performance reaching $4.3 million in 2022.

“The acquisition of STHoldings Group adds another powerful and resilient
brand to the THCT portfolio,” said Scott Cox, CEO of THC Therapeutics Inc.
“Anna Kaplan’s leadership and the legacy of SugarTop Buddery are exactly
the kind of values-driven, operationally resilient, and culturally iconic
assets that fit our strategy. As one of the few female-founded and
female-led cannabis companies to scale through Oregon’s challenging market
conditions, SugarTop Buddery brings authenticity, a loyal customer base,
and a unique brand DNA that cannot be replicated.

“Anna’s voice and strategic brand-building instincts will play a central
role in shaping THCT’s consumer strategy across our entire portfolio,”
added Cox. “This acquisition is not just about the assets—it’s about the
people, the purpose, and the power of culture in shaping long-term brand
value.”

With this acquisition, THCT deepens its operational presence in Oregon and
strengthens its foundation for a bi-coastal, vertically integrated national
cannabis platform. The Company remains focused on acquiring proven
operators and market-leading brands in cultivation, manufacturing, and
distribution—brands that resonate with consumers and reflect cannabis
culture’s highest values.
About SugarTop Buddery

Founded in 2015, SugarTop Buddery is a family-owned and -operated
vertically licensed cannabis company based in Eugene, Oregon. Over the past
decade, the company has maintained every license type available in Oregon’s
regulated market, including cultivation, processing, wholesale, and retail.
Known for its commitment to no-till, living soil craft cultivation,
SugarTop was Oregon’s first branded pre-roll company and the first to
introduce a 10-pack of pre-rolls to the state. In addition to the brand’s
products, SugarTop Buddery offers contract manufacturing services and
full-service statewide distribution.
About THC Therapeutics Inc.

THC Therapeutics Inc. (OTC: THCT) is a U.S. public company focused on
acquiring and operating a portfolio of synergistic assets and companies
within the legal cannabis industry. With a bi-coastal focus, our vertically
integrated business model positions our portfolio for rapid growth in
cultivation, manufacturing, and distribution.